| Getting at systemic risk via an agent-based model of the housing market J Geanakoplos, R Axtell, DJ Farmer, P Howitt, B Conlee, J Goldstein, ... American Economic Review 102 (3), 53-58, 2012 | 271 | 2012 |
| Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy AM Moreno, N Palmer, F Alemán, G Chen, A Pla, N Jiang, W Leong Chew, ... Nature biomedical engineering 3 (10), 806-816, 2019 | 98 | 2019 |
| Long-lasting analgesia via targeted in situ repression of NaV1.7 in mice AM Moreno, F Alemán, GF Catroli, M Hunt, M Hu, A Dailamy, A Pla, ... Science translational medicine 13 (584), eaay9056, 2021 | 81 | 2021 |
| An agent-based model of the housing market bubble in metropolitan washington dc R Axtell, JD Farmer, J Geanakoplos, P Howitt, E Carrella, B Conlee, ... Benjamin and Goldstein, Jon and Hendrey, Matthew and Kalikman, Philip and …, 2014 | 50 | 2014 |
| Regulation of the embryonic cell cycle during mammalian preimplantation development N Palmer, P Kaldis Current topics in developmental biology 120, 1-53, 2016 | 35 | 2016 |
| Discovery of a chemical probe for PRDM9 A Allali-Hassani, MM Szewczyk, D Ivanochko, SL Organ, J Bok, JSY Ho, ... Nature communications 10 (1), 5759, 2019 | 30 | 2019 |
| Translating CRISPR-Cas therapeutics: approaches and challenges LS Tay, N Palmer, R Panwala, WL Chew, P Mali The CRISPR Journal 3 (4), 253-275, 2020 | 29 | 2020 |
| Diverse roles for CDK‐associated activity during spermatogenesis N Palmer, SZA Talib, P Kaldis FEBS letters 593 (20), 2925-2949, 2019 | 24 | 2019 |
| Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity D Katrekar, Y Xiang, N Palmer, A Saha, D Meluzzi, P Mali Elife 11, e75555, 2022 | 22 | 2022 |
| Less-well known functions of cyclin/CDK complexes N Palmer, P Kaldis Seminars in cell & developmental biology 107, 54-62, 2020 | 22 | 2020 |
| A novel function for CDK2 activity at meiotic crossover sites N Palmer, SZA Talib, P Singh, CMF Goh, K Liu, JC Schimenti, P Kaldis PLoS Biology 18 (10), e3000903, 2020 | 22 | 2020 |
| CDK2 kinase activity is a regulator of male germ cell fate P Singh, RK Patel, N Palmer, JK Grenier, D Paduch, P Kaldis, A Grimson, ... Development 146 (21), dev180273, 2019 | 21 | 2019 |
| The CDK1-TOPBP1-PLK1 axis regulates the Bloom’s syndrome helicase BLM to suppress crossover recombination in somatic cells C Balbo Pogliano, I Ceppi, S Giovannini, V Petroulaki, N Palmer, F Uliana, ... Science Advances 8 (5), eabk0221, 2022 | 15 | 2022 |
| Exploring protein orthogonality in immune space: a case study with AAV and Cas9 orthologs AM Moreno, N Palmer, F Alemán, G Chen, A Pla, WL Chew, M Law, ... BioRxiv, 245985, 2018 | 14 | 2018 |
| CDK2 regulates the NRF1/Ehmt1 axis during meiotic prophase I N Palmer, SZA Talib, CK Ratnacaram, D Low, X Bisteau, JHS Lee, ... Journal of Cell Biology 218 (9), 2896-2918, 2019 | 12 | 2019 |
| Peptide-tiling screens of cancer drivers reveal oncogenic protein domains and associated peptide inhibitors KM Ford, R Panwala, DH Chen, A Portell, N Palmer, P Mali Cell systems 12 (7), 716-732. e7, 2021 | 11 | 2021 |
| The Econ-ARK and HARK: Open Source Tools for Computational Economics. CD Carroll, AM Kaufman, JL Kazil, NM Palmer, MN White SciPy, 25-30, 2018 | 10 | 2018 |
| NF-κB as a Potential Molecular Target for Therapy of Gastrointestinal Cancers N Palmer, MK Shanmugam, G Sethi, P Kaldis Therapeutic targets for inflammation and cancer: Novel therapies for …, 2017 | 4 | 2017 |
| 568P First-in-human anti-ALPP CAR-T cell immunotherapy for ovarian and endometrial cancer B Zhu, Q Jia, R Chen, G Chen, L Zhao, N Palmer, D Xiang, F Chen, ... Annals of Oncology 33, S807, 2022 | 3 | 2022 |
| Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA base-editing activity, functionality and specificity D Katrekar, N Palmer, Y Xiang, A Saha, D Meluzzi, P Mali Biorxiv, 2020.09. 08.288233, 2020 | 3 | 2020 |
